Given the lack of effective therapies and the apparent safety of this class of PI3K inhibitors, alpelisib is a promising candidate for drug repurposing in Lowe syndrome and Dent disease. The gene discussed is PIK3CD; the disease is oculocerebrorenal syndrome.